High Point Advisor Group LLC Abb Vie Inc. Transaction History
High Point Advisor Group LLC
- $2.05 Billion
- Q3 2025
A detailed history of High Point Advisor Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 182,897 shares of ABBV stock, worth $42.8 Million. This represents 2.07% of its overall portfolio holdings.
Number of Shares
182,897
Previous 180,370
1.4%
Holding current value
$42.8 Million
Previous $33.5 Million
26.48%
% of portfolio
2.07%
Previous 1.82%
Shares
27 transactions
Others Institutions Holding ABBV
# of Institutions
4,490Shares Held
1.28BCall Options Held
17.1MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...